Notably, these two NOS3 gene SNPs have been studied in relation to cancers such as breast, prostate, colorectal, and lung cancers, with evidence suggesting that these SNPs may influence tumor progression by modulating NO production and vascularity [32,33,34,35]. This evidence concerns the gene NOS3 and neoplasm.